The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner immunotherapy market. However, stringent regulatory policies and side-effects associated with cancer therapy are the major factors restraining the growth of this market.
Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/collections/marketsandmarkets/products/cancer-immunotherapy-market-by-type-monoclonal-antibodies-cancer-vaccines-check-point-inhibitors-immunomodulators-application-lung-breast-colorectal-melanoma-prostate-head-neck-end-user-hospital-and-clinics-global-forecast-to-2021#tab-questions
The global cancer immunotherapy market has been segmented on the basis of type, application, end user, and region. The monoclonal antibodies segment is expected to register the highest growth rate in the cancer immunotherapy market, by type, during the forecast period. Factors such as high success rate and less recovery time are contributing to the high growth in this segment.
Based on application, the global cancer immunotherapy market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and others (renal cell carcinoma, cervical, gastric, and lymphoma). The lung cancer segment is expected to witness the highest CAGR from 2016 to 2021, primarily due to the rising prevalence of this type of cancer.
Based on end users, the global cancer immunotherapy market is segmented into hospitals and clinics & others. The hospitals segment is expected to account for the largest share of the global cancer immunotherapy market in 2016. The rise in healthcare spending has resulted in the increasing use of drugs in hospitals.
Geographically, the cancer immunotherapy market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of North America can be attributed to the growing aging population and the increased funding from government and non-government agencies in order to increase the research capacity.
Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the cancer immunotherapy market.
Read More about this report: https://watchersofmarkets.com/collections/marketsandmarkets/products/cancer-immunotherapy-market-by-type-monoclonal-antibodies-cancer-vaccines-check-point-inhibitors-immunomodulators-application-lung-breast-colorectal-melanoma-prostate-head-neck-end-user-hospital-and-clinics-global-forecast-to-2021
The major players in the cancer immunotherapy market include Amgen (U.S.), AstraZeneca (U.K.), F. Hoffman La-Roche Ltd. (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).
Related Report:
Global Cancer Treatment Drugs Market Analysis 2012-2017 and Forecast 2018-2023
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The global Cancer Treatment Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cancer Treatment Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Read More: https://watchersofmarkets.com/products/global-cancer-treatment-drugs-market-analysis-2012-2017-and-forecast-2018-2023
About Us:
We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.
Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.
Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website: https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id : sales@watchersofmarkets.com